跳至主要内容
临床试验/ISRCTN80782810
ISRCTN80782810已完成未知

A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)

Cambridge University Hospitals NHS Foundation Trust and University of Cambridge0 个研究点目标入组 748 人开始时间: 2015年8月7日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
748

研究概览

简要总结

  1. 2018 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/30514400 2. 2019 statistical analysis plan in ncbi.nlm.nih.gov/pubmed/31822298 (added 12/12/2019) 3. 2020 results in https://pubmed.ncbi.nlm.nih.gov/33326713/ (added 17/12/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Informed consent
  • 2. Adults aged 16 or older
  • 3. Symptomatic cSDH confirmed on cranial imaging (predominantly hypodense or isodense crescentic collection along the cerebral convexity on CT)

排除标准

  • 1. Patients who have already undergone surgical intervention for a cSDH during the same index admission
  • 2. Condition with conditions where steroids are clearly contra-indicated (i.e. active infections)
  • 3. Already on steroids
  • 4. Enrolment in same study within last 12 months
  • 5. Time interval from the time of admission to NSU to initiation of trial medication exceeds 72 hours
  • 6. cSDH in presence of CSF shunt

研究者

发起方
Cambridge University Hospitals NHS Foundation Trust and University of Cambridge

相似试验